These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
334 related articles for article (PubMed ID: 15169811)
1. Four decades of continuing innovation with fluorouracil: current and future approaches to fluorouracil chemoradiation therapy. Rich TA; Shepard RC; Mosley ST J Clin Oncol; 2004 Jun; 22(11):2214-32. PubMed ID: 15169811 [TBL] [Abstract][Full Text] [Related]
2. Evolution of 5-fluorouracil-based chemoradiation in the management of rectal cancer. Patel PA Anticancer Drugs; 2011 Apr; 22(4):311-6. PubMed ID: 21301320 [TBL] [Abstract][Full Text] [Related]
3. Capecitabine and radiation therapy for advanced gastrointestinal malignancies. Rich T Oncology (Williston Park); 2002 Dec; 16(12 Suppl No 14):27-30. PubMed ID: 12520637 [TBL] [Abstract][Full Text] [Related]
4. Capecitabine: a review. Walko CM; Lindley C Clin Ther; 2005 Jan; 27(1):23-44. PubMed ID: 15763604 [TBL] [Abstract][Full Text] [Related]
5. Preoperative chemoradiotherapy with capecitabine versus protracted infusion 5-fluorouracil for rectal cancer: a matched-pair analysis. Das P; Lin EH; Bhatia S; Skibber JM; Rodriguez-Bigas MA; Feig BW; Chang GJ; Hoff PM; Eng C; Wolff RA; Delclos ME; Krishnan S; Janjan NA; Crane CH Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1378-83. PubMed ID: 17056196 [TBL] [Abstract][Full Text] [Related]
6. Preoperative chemoradiotherapy for rectal cancer: a comparison between intravenous 5-fluorouracil and oral capecitabine. Ramani VS; Sun Myint A; Montazeri A; Wong H Colorectal Dis; 2010 Aug; 12 Suppl 2():37-46. PubMed ID: 20618366 [TBL] [Abstract][Full Text] [Related]
7. Infusional chemoradiation for rectal and anal cancers. Rich TA Oncology (Williston Park); 1999 Oct; 13(10 Suppl 5):131-4. PubMed ID: 10550837 [TBL] [Abstract][Full Text] [Related]
8. The use of capecitabine in the combined-modality therapy for rectal cancer. Liauw SL; Minsky BD Clin Colorectal Cancer; 2008 Mar; 7(2):99-104. PubMed ID: 18501068 [TBL] [Abstract][Full Text] [Related]
9. Bolus 5-Fluorouracil as an alternative modality to infusion 5-Fluorouracil in a patient with rectal cancer and capecitabine-induced cardiotoxicity. Shaib W; Lee V; Saif MW In Vivo; 2009; 23(5):821-6. PubMed ID: 19779118 [TBL] [Abstract][Full Text] [Related]
10. [Timeline from discovery of 5-FU to development of an oral anticancer agent S-1 and its drug concept]. Shirasaka T; Taguchi T Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():4-18. PubMed ID: 16897967 [TBL] [Abstract][Full Text] [Related]
11. Capecitabine and radiotherapy as neoadjuvant treatment for rectal cancer. Ben-Josef E Am J Clin Oncol; 2007 Dec; 30(6):649-55. PubMed ID: 18091061 [TBL] [Abstract][Full Text] [Related]
12. Safety of capecitabine: a review. Mikhail SE; Sun JF; Marshall JL Expert Opin Drug Saf; 2010 Sep; 9(5):831-41. PubMed ID: 20722491 [TBL] [Abstract][Full Text] [Related]
13. The role of UFT in combined-modality therapy. Blanke CD; Teng M; Choy H Oncology (Williston Park); 1999 Oct; 13(10 Suppl 5):47-54. PubMed ID: 10550826 [TBL] [Abstract][Full Text] [Related]
14. Capecitabine in the treatment of esophageal and gastric cancers. Popa EC; Shah MA Expert Opin Investig Drugs; 2013 Dec; 22(12):1645-57. PubMed ID: 24090307 [TBL] [Abstract][Full Text] [Related]
16. Where do we stand with 5-fluorouracil? Schmoll HJ; Büchele T; Grothey A; Dempke W Semin Oncol; 1999 Dec; 26(6):589-605. PubMed ID: 10606252 [TBL] [Abstract][Full Text] [Related]
17. Emerging role of capecitabine in gastric cancer. Comella P; Franco L; Casaretti R; de Portu S; Menditto E Pharmacotherapy; 2009 Mar; 29(3):318-30. PubMed ID: 19249950 [TBL] [Abstract][Full Text] [Related]
18. Molecular chemotherapy combined with radiation therapy enhances killing of cholangiocarcinoma cells in vitro and in vivo. Pederson LC; Buchsbaum DJ; Vickers SM; Kancharla SR; Mayo MS; Curiel DT; Stackhouse MA Cancer Res; 1997 Oct; 57(19):4325-32. PubMed ID: 9331094 [TBL] [Abstract][Full Text] [Related]